ASX Announcement ASX : ENP 19 October 2026 TRP-8803 clinical data presented at 39th ECNP Congress showed rapid & consistent psychedelic effects in Binge Eating Disorder patients Melbourne, Australia – Entropy Neurodynamics Limited (‘Entropy’ or the ‘Company’) (ASX: ENP), a...
Entropy presents promising TRP-8803 clinical data at ECNP
Filed with ASX ·
6ix hasn’t read this filing yet.
Entropy Neurodynamics Limited on 6ix
Earlier from Entropy Neurodynamics
- Change of Director's Interest Notice - HJ
- Cleansing Notice
- Application for quotation of securities - ENP
- TRP-8803 60-Minute Infusion Achieved in Phase 2 BED Study
- 2026 AGM Notice of Meeting, Letter of Access and Proxy
Later from Entropy Neurodynamics
All Entropy Neurodynamics news releasesFollow Entropy Neurodynamics into a list and get an email when it puts out news.
Follow Entropy Neurodynamics